Visits: 3549, Avg visit time (secs): 419,97 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 1660 | 46,77% | |
| /lilly/programme/efsd-lilly-rfa08.html | 676 | 19,05% |
| /programmes.html | 493 | 13,89% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa08.html | 178 | 5,02% |
| /msd/albert-renold/efsd-msd-arenold.html | 46 | 1,30% |
| /gsk/efsd-gsk-rfa08.html | 43 | 1,21% |
| /novo-t2/efsd-novo-t2-rfa08.html | 35 | 0,99% |
| /home.html | 25 | 0,70% |
| /novartis/efsd-novartis-rfa09.html | 23 | 0,65% |
| /lilly/programme/efsd-lilly-cds-fellowship08.htm | 22 | 0,62% |
| /regulations.html | 19 | 0,54% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 1527 | 43,03% |
| /lilly/programme/efsd-lilly-rfa08.html | 688 | 19,39% |
| /programmes.html | 296 | 8,34% |
| /msd/albert-renold/efsd-msd-arenold.html | 256 | 7,21% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa08.html | 113 | 3,18% |
| /home.html | 82 | 2,31% |
| /gsk/efsd-gsk-rfa08.html | 63 | 1,78% |
| /novo-t2/efsd-novo-t2-rfa08.html | 35 | 0,99% |
| /lilly/fellowships/efsd-lilly-fship09.html | 31 | 0,87% |
| /lifescan/efsd-lifescan-rfa09.html | 31 | 0,87% |
| /pfizer/efsd-pfizer-rfa09.html | 25 | 0,70% |